ANAB
#2141
AnaptysBio, Inc. - Common Stock
57.2 9 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.22%
Monthly Change
+9.50%
6 month change
+6.49%
Year Change
+62.76%
Previous Close
58.0 0
Open
57.2 9
Low
57.2 9
High
57.2 9
Volume
60
Financials
- Market Capitalization 1.67 B
- Employee 104
- Founded 2005
- CEO N/A
- Website www.anaptysbio.com
- Headquarter Delaware, United States
- FIGI BBG0026ZDHR0
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-105.39
Price to sales ratio
5.94
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2097 |  GHRS GH Research PLC - Ordinary Shares | 28.65 USD | -1.24% | -0.62% | +2.54% | +102.33% | 1.78 B USD | ||
| 2109 |  AAPG Ascentage Pharma Group International - American Depository Shar | 18.73 USD | +10.83% | +9.21% | +2.29% | -25.08% | 1.75 B USD | ||
| 2146 |  BCAX Bicara Therapeutics Inc. - Common Stock | 24.83 USD | +0.40% | +0.40% | -7.63% | +71.95% | 1.64 B USD | ||
| 2150 |  FBRX Forte Biosciences, Inc. - Common Stock | 76.99 USD | 0.00% | +0.08% | +0.50% | +162.32% | 1.63 B USD |
Frequently asked questions about AnaptysBio, Inc. Common Stock
What is the AnaptysBio, Inc. Common Stock stock price today?
The current price of AnaptysBio, Inc. Common Stock (ANAB) is 57.29. Over the past 24 hours, the stock has changed by -1.22%. Follow the ANAB chart for real-time price dynamics.
What is the stock ticker of AnaptysBio, Inc. Common Stock?
AnaptysBio, Inc. Common Stock trades under the ticker ANAB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AnaptysBio, Inc. Common Stock stock going up?
ANAB has changed by +0.10% over the last week, +9.50% over the last month, and +62.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of AnaptysBio, Inc. Common Stock?
AnaptysBio, Inc. Common Stock currently has a market capitalization of 1.67 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were AnaptysBio, Inc. Common Stock earnings last quarter?
Last quarter, AnaptysBio, Inc. Common Stock reported earnings of -1.84 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was AnaptysBio, Inc. Common Stock revenue for the last quarter?
AnaptysBio, Inc. Common Stock reported quarterly revenue of 25.56 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was AnaptysBio, Inc. Common Stock net income for the last quarter?
AnaptysBio, Inc. Common Stock reported net income of -52.88 M for the last quarter. The previous quarter showed 49.61 M, which means net income changed by -206.59%.
How many employees does AnaptysBio, Inc. Common Stock have?
As of the latest available data, AnaptysBio, Inc. Common Stock has 104 employees. Workforce size can provide additional context about the company's scale and operations.
What is AnaptysBio, Inc. Common Stock EBITDA?
AnaptysBio, Inc. Common Stock EBITDA is -34.51 M, and its EBITDA margin is -135.03%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AnaptysBio, Inc. Common Stock stock?
You can buy AnaptysBio, Inc. Common Stock (ANAB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AnaptysBio, Inc. Common Stock stock?
Investing in AnaptysBio, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANAB chart and related analysis on metatrader.com as part of your research.